- Alcami Corporation is expanding its laboratory services at its Creekstone Drive facility in Durham, North Carolina.
- The 20,000-square-foot expansion will enhance analytical capabilities to support biologics, peptides, oligonucleotides, ADCs, and cell and gene therapies.
Alcami Corporation (Alcami), a U.S.-based contract development and manufacturing organisation (CDMO), has announced the expansion of its laboratory services at the Creekstone Drive facility in Durham, North Carolina. The investment is aimed at strengthening the company’s integrated solutions for pharmaceutical and biotech clients from development to delivery.
The 20,000-square-foot expansion began in the fourth quarter of 2025 and is expected to be completed in 2026. It will increase Alcami’s analytical capacity in support of biologics, peptides, oligonucleotides, antibody-drug conjugates (ADCs), and cell and gene therapy (CGT) products. The upgraded site will feature expanded resources for method establishment, release and stability testing, and biologics characterisation using advanced instrumentation in bioseparation, mass spectrometry, electrophoresis, and bioassay techniques.
“Our investment in the Durham laboratory services facility reflects Alcami’s dedication to scientific excellence, innovation, and operational agility. By expanding our capabilities, we’re enabling our clients to bring life-changing therapies to patients with greater speed and scalability.”
Katie Schlipp, President of Laboratory Services
The Creekstone Drive site forms part of Alcami’s broader U.S. network of laboratory, manufacturing, and pharmaceutical storage facilities. Its laboratory services are designed to integrate with drug product manufacturing and storage offerings, allowing clients to consolidate sourcing under a single CDMO partner.
This expansion follows other recent investments across Alcami’s network, including sterile fill-finish capacity increases at its RTP, North Carolina, and Charleston, South Carolina, facilities, as well as enhanced oral solid dose capabilities in Wilmington, North Carolina.
